PTEN and breast cancer: In HER2-positive (HER2+) BC cell-lines and xenografts, PTEN deficiency seems to contribute to Trastuzumab resistance by dephosphorylation and activation of SRC proto-oncogene nonreceptor tyrosine-protein kinase.